戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  was compared with placebo were analysed for measles antibodies.
2  were also associated with reduced levels of measles antibodies.
3 protected from measles infection by maternal measles antibodies.
4  1967-1976 had significantly lower levels of measles antibody (92.4% [95% CI, 90.8%-93.9%]) than did
5                We examined the prevalence of measles antibody among 12 349 newly hired HCP between 20
6 assess serologic response, seroprevalence of measles antibody among children aged 4-6 years in 1995 w
7                            Residual maternal measles antibodies and immunologic immaturity dampen imm
8  children vaccinated in presence of maternal measles antibody and 14.5 per 1000 person-years without
9                                Low levels of measles antibodies at birth render children susceptible
10  also associated with reduced prevaccination measles antibody concentrations and increased morbidity.
11 nd 25% (95% CI: 1, 43%), respectively, lower measles antibody concentrations at the 9-month visit amo
12                                              Measles antibody concentrations before and 8, 32, and 80
13 S were quantified in serum at inclusion, and measles antibody concentrations were assessed at inclusi
14 subjects in this study were seropositive for measles antibody, despite the fact that almost 20% of ch
15     In a combined analysis, children who had measles antibody detected when they received their first
16 cases had clinically compatible symptoms and measles antibody detection in cerebrospinal fluid (CSF)
17 le highly heterogeneous across a population, measles antibody evolution is strongly predictive from b
18 d with HIV-unexposed children (2860 mIU/mL), measles antibody geometric mean titers (GMTs) were signi
19      We investigated predictors of levels of measles antibodies in newborns in rural Kenya.
20 aria infection was associated with levels of measles antibodies in newborns.
21  maternal HIV infection may reduce levels of measles antibodies in newborns.
22 ay was used to measure the seroprevalence of measles antibody in NHANES participants 6-49 years of ag
23                 464 children with detectable measles antibody in their sample before vaccination were
24 eferred electrochemical method for detecting measles-antibodies in label-free manner.
25 rvived and returned for follow-up maintained measles antibody levels >or=120 mIU/mL, compared with 89
26 d 12-19 years who had detectable rubella and measles antibody levels in serum from the U.S. National
27 man leukocyte antigen (HLA) homozygosity and measles antibody levels was assessed in a volunteer grou
28 port capacity at delivery [fetal to maternal measles antibody (MMA) ratio].
29 ibody and 14.5 per 1000 person-years without measles antibody (MRR, 0.29; 95% CI, .09-.91).
30 g HIV-uninfected children, the difference in measles antibody prevalence at age 12 months between one
31               Among HIV-uninfected children, measles antibody prevalence was lower among 1- than 2-do
32             Previously, we demonstrated that measles antibody prevalence was lower at age 12 months a
33 ts born to mothers with history of wild-type measles, antibody responses among children born to vacci
34            Children previously identified as measles antibody seronegative or equivocal after 1 dose
35 130 children reimmunized, 106 (81.5%) became measles antibody seropositive, but 24 children (18.5%) r
36 We included observational studies presenting measles antibody seroprevalence data from infants <9 mon
37 d 35.1% (95% CI, 9.8%-53.2%) lower levels of measles antibodies than did those born to HIV-uninfected
38                                              Measles antibody titers were measured by enzyme-linked i
39                                              Measles antibody waning in vaccinated populations should
40               Overall, the seroprevalence of measles antibodies was 0.75 (95% CI, 0.72-0.78), and the
41 sles vaccination in the presence of maternal measles antibodies was associated with reduced all-cause
42                The highest seroprevalence of measles antibody was in non-Hispanic blacks (98.6% [95%
43                                  Testing for measles antibody was included in the National Health and
44                                              Measles antibody was measured a minimum of 6 weeks later
45 Multivariate analysis showed that absence of measles antibody was significantly associated with young
46 urvival if given in the presence of maternal measles antibody, we reanalyzed data from 2 previously p
47                             Children without measles antibodies were more likely to have never receiv